MX2021013347A - Metodo para tratar el dolor asociado con endometriosis mediante el uso de un compuesto de diaminopirimidina. - Google Patents
Metodo para tratar el dolor asociado con endometriosis mediante el uso de un compuesto de diaminopirimidina.Info
- Publication number
- MX2021013347A MX2021013347A MX2021013347A MX2021013347A MX2021013347A MX 2021013347 A MX2021013347 A MX 2021013347A MX 2021013347 A MX2021013347 A MX 2021013347A MX 2021013347 A MX2021013347 A MX 2021013347A MX 2021013347 A MX2021013347 A MX 2021013347A
- Authority
- MX
- Mexico
- Prior art keywords
- associated pain
- diaminopyrimidine compound
- treating endometriosis
- compound
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
(ver Fórmula) Método para tratar, resistir y aliviar el dolor asociado con endometriosis, relacionado con el campo de la medicina biológica, que comprende administrar, a una persona que lo necesite, una cantidad terapéuticamente eficaz de un compuesto de diaminopirimidina de fórmula (I) o una sal, un éster, un estereoisómero, un polimorfo, un solvato, un N-óxido, un compuesto marcado isotópicamente, un metabolito o un profármaco del mismo farmacéuticamente aceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019085209 | 2019-04-30 | ||
PCT/CN2020/087689 WO2020221277A1 (zh) | 2019-04-30 | 2020-04-29 | 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021013347A true MX2021013347A (es) | 2022-01-24 |
Family
ID=73028778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021013347A MX2021013347A (es) | 2019-04-30 | 2020-04-29 | Metodo para tratar el dolor asociado con endometriosis mediante el uso de un compuesto de diaminopirimidina. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220249478A1 (es) |
EP (1) | EP3960178A4 (es) |
JP (1) | JP2022531570A (es) |
KR (1) | KR20220008286A (es) |
CN (1) | CN114007620B (es) |
AU (1) | AU2020266947A1 (es) |
BR (1) | BR112021021838A8 (es) |
CA (1) | CA3138238A1 (es) |
MX (1) | MX2021013347A (es) |
SG (1) | SG11202111960PA (es) |
TW (1) | TWI737285B (es) |
WO (1) | WO2020221277A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018361276B2 (en) * | 2017-11-01 | 2022-11-24 | Beijing Tide Pharmaceutical Co., Ltd. | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
MA43821A (fr) * | 2016-03-14 | 2018-11-28 | Afferent Pharmaceuticals Inc | Pyrimidines et variantes de celles-ci, et leurs utilisations |
US10662162B2 (en) * | 2016-03-25 | 2020-05-26 | Afferent Pharmaceuticals, Inc. | Pyrimidines and variants thereof, and uses therefor |
AU2018361276B2 (en) * | 2017-11-01 | 2022-11-24 | Beijing Tide Pharmaceutical Co., Ltd. | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof |
-
2020
- 2020-04-29 MX MX2021013347A patent/MX2021013347A/es unknown
- 2020-04-29 EP EP20798599.5A patent/EP3960178A4/en active Pending
- 2020-04-29 CA CA3138238A patent/CA3138238A1/en active Pending
- 2020-04-29 CN CN202080032509.8A patent/CN114007620B/zh active Active
- 2020-04-29 WO PCT/CN2020/087689 patent/WO2020221277A1/zh unknown
- 2020-04-29 JP JP2021564186A patent/JP2022531570A/ja active Pending
- 2020-04-29 US US17/607,475 patent/US20220249478A1/en active Pending
- 2020-04-29 SG SG11202111960PA patent/SG11202111960PA/en unknown
- 2020-04-29 KR KR1020217038622A patent/KR20220008286A/ko unknown
- 2020-04-29 BR BR112021021838A patent/BR112021021838A8/pt unknown
- 2020-04-29 AU AU2020266947A patent/AU2020266947A1/en active Pending
- 2020-04-30 TW TW109114698A patent/TWI737285B/zh active
Also Published As
Publication number | Publication date |
---|---|
SG11202111960PA (en) | 2021-12-30 |
CN114007620B (zh) | 2024-08-06 |
EP3960178A4 (en) | 2023-01-25 |
KR20220008286A (ko) | 2022-01-20 |
TW202106303A (zh) | 2021-02-16 |
BR112021021838A8 (pt) | 2023-02-28 |
AU2020266947A1 (en) | 2021-12-16 |
TWI737285B (zh) | 2021-08-21 |
EP3960178A1 (en) | 2022-03-02 |
WO2020221277A1 (zh) | 2020-11-05 |
BR112021021838A2 (pt) | 2022-01-04 |
CN114007620A (zh) | 2022-02-01 |
CA3138238A1 (en) | 2020-11-05 |
US20220249478A1 (en) | 2022-08-11 |
JP2022531570A (ja) | 2022-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2024004332A (es) | Metodos de uso de inhibidores de ehmt2 para tratar o prevenir transtornos sanguíneos. | |
MX2021000887A (es) | Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer. | |
MX2022006865A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio. | |
MX2019013574A (es) | Amidas de piridona deuteradas y sus profarmacos como moduladores de los canales de sodio. | |
MX2010001189A (es) | Derivados de naftiridina como modulares del canal de potasio. | |
MX2021007970A (es) | Derivado de 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y uso medico del mismo. | |
PH12018501390A1 (en) | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof | |
SA515360229B1 (ar) | مثبطات عامل التمايز والنمو 8 | |
WO2011126910A3 (en) | Compositions and methods for the treatment of somatosensory disorders | |
MX2013012588A (es) | Inhibidores de cinasa. | |
BR112021017354A2 (pt) | Método para o tratamento de doença hepática adiposa e/ou esteatoepatite | |
BR112013021566A2 (pt) | composto de fórmula, ou um aduto ou sal farmaceuticamente aceitável do mesmo e método de prevenção e/ou tratamento de um indivíduo que compreende a administração ao dito indivíduo uma quantidade terapeuticamente eficaz de um composto de fórmula | |
BR112021026214A2 (pt) | Método para tratamento de fibrose pulmonar idiopática | |
WO2013085849A3 (en) | Sulfate esters of noribogaine | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
EA202091604A1 (ru) | Ингибирование ионного канала a1 с транзиторным рецепторным потенциалом | |
AU2018282104A1 (en) | Use of vibegron to treat overactive bladder | |
ZA202311035B (en) | Phosphonyl derivative, and composition and pharmaceutical application thereof | |
MX2021003662A (es) | Derivado de aminonorbornano y metodo de fabricacion del mismo y uso del mismo. | |
MX2023001671A (es) | Procedimiento y compuesto para su uso en el tratamiento y/o prevención de la netosis. | |
PH12021551057A1 (en) | Macrocyclic tyrosine kinase inhibitor and uses thereof | |
MX2021009539A (es) | Derivado del profarmaco 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y aplicacion del mismo en medicina. | |
WO2017165822A8 (en) | Small molecule inhibitor of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer | |
MX2024000807A (es) | Inhibidor de aak1 y uso de este. | |
MX2021013347A (es) | Metodo para tratar el dolor asociado con endometriosis mediante el uso de un compuesto de diaminopirimidina. |